Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment
Paper deals with the content of CD95+-cells in the blood of patients with ovarian cancer and benign tumors. Found that patients with a malignant process and low CD95+-cells before treatment and during chemotherapy have a poor survival. The initial increase in the relative level CD95+- cells has no e...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/45 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849303192601362432 |
|---|---|
| author | N. G. Kormosh T. N. Zabotina |
| author_facet | N. G. Kormosh T. N. Zabotina |
| author_sort | N. G. Kormosh |
| collection | DOAJ |
| description | Paper deals with the content of CD95+-cells in the blood of patients with ovarian cancer and benign tumors. Found that patients with a malignant process and low CD95+-cells before treatment and during chemotherapy have a poor survival. The initial increase in the relative level CD95+- cells has no effect on survival, increasing the relative level CD95+-cells during chemotherapy is associated with poor survival. Concluded that the CD95 can not be a factor in the forecast, but the reaction of the organism to maintain its level within the physiological range in the treatment of ovarian cancer patients can achieve significantly better long-term results. |
| format | Article |
| id | doaj-art-c851a498d50a4d9bb79bf1273250f8bd |
| institution | Kabale University |
| issn | 1994-4098 1999-8627 |
| language | Russian |
| publishDate | 2014-07-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Опухоли женской репродуктивной системы |
| spelling | doaj-art-c851a498d50a4d9bb79bf1273250f8bd2025-08-20T04:00:02ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0101-2839210.17650/1994-4098-2013-0-1-2-83-9260Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatmentN. G. Kormosh0T. N. Zabotina1N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowPaper deals with the content of CD95+-cells in the blood of patients with ovarian cancer and benign tumors. Found that patients with a malignant process and low CD95+-cells before treatment and during chemotherapy have a poor survival. The initial increase in the relative level CD95+- cells has no effect on survival, increasing the relative level CD95+-cells during chemotherapy is associated with poor survival. Concluded that the CD95 can not be a factor in the forecast, but the reaction of the organism to maintain its level within the physiological range in the treatment of ovarian cancer patients can achieve significantly better long-term results.https://ojrs.abvpress.ru/ojrs/article/view/45ovarian cancerсd95+-t-limphocytes |
| spellingShingle | N. G. Kormosh T. N. Zabotina Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment Опухоли женской репродуктивной системы ovarian cancer сd95+-t-limphocytes |
| title | Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment |
| title_full | Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment |
| title_fullStr | Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment |
| title_full_unstemmed | Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment |
| title_short | Evolution of СD95+-cells in peripheral blood of patients with ovarian cancer in during the combined treatment |
| title_sort | evolution of сd95 cells in peripheral blood of patients with ovarian cancer in during the combined treatment |
| topic | ovarian cancer сd95+-t-limphocytes |
| url | https://ojrs.abvpress.ru/ojrs/article/view/45 |
| work_keys_str_mv | AT ngkormosh evolutionofsd95cellsinperipheralbloodofpatientswithovariancancerinduringthecombinedtreatment AT tnzabotina evolutionofsd95cellsinperipheralbloodofpatientswithovariancancerinduringthecombinedtreatment |